Cargando…
Short Synthesis of Molnupiravir (EIDD-2801) via a Thionated Uridine Intermediate
[Image: see text] Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a concise synthesis of the drug via a novel thionated derivative that relies on one-pot methodologies, thus...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552467/ https://www.ncbi.nlm.nih.gov/pubmed/34723033 http://dx.doi.org/10.1021/acsomega.1c04550 |